Introduction
Matthew Schissler net worth is estimated at $5 million to $10 million in 2026, although no complete public financial disclosure confirms an exact figure. This article focuses on Matthew L. Schissler, the American entrepreneur, biotech executive, investor, and business advisor associated with Cord Blood America, Pyrenees Investments, Work Your Core Investments, and several small-cap companies.
Rather than relying on unsupported online wealth claims, this guide examines the business activities and public career information behind the estimate. You will learn about Schissler’s early sales and advertising career, his leadership at Cord Blood America, acquisitions and capital raising, investment and advisory work, board positions, reported ownership interests, and the reasons his overall wealth remains difficult to verify precisely.
Matthew Schissler Life Story
Matthew L. Schissler is an American entrepreneur and investor whose public career spans advertising, biotechnology, private investment, consulting, and corporate board work. He became best known for his leadership at Cord Blood America, which he co-founded in 2003 and led as Chairman and CEO until 2012. His later activities expanded into small-cap investing, advisory work, and positions across several industries.
Matthew Schissler Profile Summary
| Detail | Information |
| Full Name | Matthew L. Schissler |
| Date of Birth | June 9, 1971 |
| Age in 2026 | 54 years old |
| Current Locations | Fort Lauderdale, Florida, and Paradise Valley, Arizona |
| Education | BA in Biology and Public Policy from St. Mary’s College of Maryland, 1993 |
| Securities Licenses | Series 63 and Series 79 |
| Career Beginning | Started in sales at Delmarva Broadcasting |
| Early Career Role | Senior Regional Director at TMP Worldwide from 1994 to 2001 |
| First Company Founded | RainMakers International, a direct response advertising company, was founded in 2001 |
| Major Company | Cord Blood America Inc. (CBAI, OTCBB), founded in 2003 |
| CBAI Leadership Role | Chairman and CEO from 2003 to 2012 |
| Capital Raised at CBAI | More than $30 million |
| Major CBAI Acquisitions | CorCell Inc., Cryobank for Oncologic and Reproductive Donors, and BioCells Argentina |
| Award Recognition | Ernst and Young Entrepreneur of the Year, Los Angeles semi-finalist, 2008 |
| Current Firms | Work Your Core Investments LLC and Pyrenees Investments LLC |
| Board Roles | Aztec Airways Inc., Big League Wiffle Ball, and IIOT-OXYS Inc. |
| GHS Ownership | Approximately 33% stake |
| Other Companies | Frozen Food Gift Group (FROZ, 2009) and China Stem Cells Inc. |
| Estimated Net Worth in 2026 | $5 million to $10 million |
Matthew Schissler Early Life and Education
Matthew Schissler was born on June 9, 1971, and studied at St. Mary’s College of Maryland from 1989 to 1993, where he earned a Bachelor of Arts in Biology and Public Policy. This mix of science and policy later became important in his business career, especially when he entered the healthcare and biotechnology space. Biology helped him understand cord blood stem cells, medical preservation, and the science behind biotech work, while Public Policy gave him a clearer view of healthcare rules, governance, and regulation.
Schissler’s degree in Biology and Public Policy provided an academic background relevant to both science and policy. His later career moved into healthcare and biotechnology, including his leadership role at Cord Blood America. The available information supports the connection between his education and career field, but it does not establish that his degree directly caused the company’s growth.
Matthew Schissler Career Start and Sales Background
Matthew Schissler began his career in sales after graduating from St. Mary’s College in 1993, first working at Delmarva Broadcasting, a regional radio and media company. That early media sales role helped him build communication skills, direct-to-consumer experience, and confidence in persuasion-based business. From 1994 to 2001, he worked at TMP Worldwide Inc., a major staffing and advertising company active in executive search, recruitment advertising, and early internet-based hiring platforms.
During those seven years, he held sales and management roles, eventually rising to Senior Regional Director. His work involved client relationships, team building, revenue targets, and managing business operations during the dot-com era. This experience gave him the commercial foundation, leadership discipline, and business-building mindset he later used when starting his own companies.
Matthew Schissler’s First Business Venture
Matthew Schissler’s first business venture began in April 2001, after he left TMP Worldwide and founded RainMakers International, a direct response advertising agency. He served as President and CEO of the company from the company’s founding until January 2003, giving him direct experience in ownership, agency management, and business development. RainMakers focused on marketing campaigns designed to create immediate and measurable audience responses, which required both creative execution and strong performance analysis.
During this period, Schissler managed client relationships, campaign results, creative output, and daily agency operations. Although he ran RainMakers for about two years, the experience helped him build practical leadership, client management, and business growth skills before a new opportunity moved him toward his next major chapter with Cord Blood America.
Matthew Schissler and Cord Blood America
Matthew Schissler co-founded Cord Blood America Inc., commonly known as CBAI, in January 2003. The healthcare and biotechnology company became the most important chapter of his career, shaping his public business profile and long-term career growth. Schissler served as Chairman of the Board and Chief Executive Officer from the company’s beginning until 2012, giving him nearly nine years of leadership experience. His role at Cord Blood America showed his ability to lead a public company, manage corporate development, and build credibility in the healthcare business.
What Is Cord Blood Banking?
Cord blood banking is the process of collecting and storing blood left in the umbilical cord and placenta after a baby is born. This blood contains stem cells that may be used in future medical treatments for certain cancers, blood disorders, and immune system deficiencies. In 2003, when Matthew Schissler built Cord Blood America, this idea was still new to many families and not yet part of mainstream healthcare decisions.
Most expectant parents had little awareness of the service, and the market was still small, fragmented, and without a dominant leader. Schissler saw that gap early and turned cord blood banking into a business opportunity by building a company around a clear future healthcare need.
Matthew Schissler and CBAI’s Acquisition Growth
Matthew Schissler did not grow CBAI only through slow organic expansion. He used acquisitions to increase the company’s storage capacity, client base, infrastructure, and market position in the private cord blood banking industry. In 2005, CBAI absorbed Cord Partners Inc., which helped strengthen its private family stem cell banking services. In 2006, the company acquired assets from Cryobank for Oncologic and Reproductive Donors, adding about 750 umbilical cord blood samples and cryogenic storage infrastructure.
CBAI also acquired CorCell Inc., then one of the largest cord blood banks in the United States, which helped move the company from a smaller player toward a stronger industry position. Schissler also expanded beyond the U.S. by establishing BioCells Argentina as a South American subsidiary, showing that he saw cord blood banking as a global healthcare opportunity.
Across his time at CBAI, Schissler raised more than $30 million to support five asset acquisitions, two stock purchases, and three minority investments. For a small-cap public company in a niche healthcare sector, that was a serious achievement because it required investor trust, a clear business story, public company reporting, and compliance discipline.
Cord Blood America’s growth during Schissler’s tenure involved acquisitions, capital raising, and expansion beyond its original operations. The company traded publicly under the CBAI ticker and pursued several acquisitions and investments, including businesses and assets connected with cord blood storage. These activities are central to understanding Schissler’s role at the company and the prominence of CBAI in his career.
Matthew Schissler’s 2008 Business Recognition
Matthew Schissler received notable recognition in 2008 after being selected as a regional semi-finalist for the Ernst & Young Entrepreneur of the Year award in Los Angeles. The recognition came during a key growth period for CBAI, making it an important moment in his professional career. Ernst and Young’s Entrepreneur of the Year program is one of the most respected business award programs in the United States, so the semi-finalist status added credibility to Schissler’s public business profile.
It also showed that his leadership, company growth, and entrepreneurial work were being noticed beyond the cord blood banking industry. In a net worth article, this recognition is useful because it shows that his business achievements were acknowledged outside his own companies.
Matthew Schissler’s Las Vegas Move and CBAI Exit
During Schissler’s tenure, Cord Blood America moved its headquarters to Las Vegas, Nevada. He continued leading the company until 2012, when he left his positions as Chairman and CEO. His departure marked a transition from operating-company leadership toward the investment, consulting, and board activities associated with the later part of his career.
By 2012, after spending nine years building CBAI through acquisitions, international expansion, and major capital raises, Schissler stepped down from his Chairman and CEO roles. This exit marked a shift in his wealth strategy, moving away from single-company leadership and toward board roles, investment management, portfolio diversification, and a broader model of long-term wealth creation.
How Matthew Schissler’s Net Worth Is Estimated
Matthew Schissler’s 2026 net worth cannot be confirmed through a complete public financial statement. The available information instead provides details about his business career, investment interests, reported ownership positions, advisory activities, and corporate affiliations.
The $5 million to $10 million range used here should therefore be treated as an estimate, not an audited figure. A precise calculation would require current valuations of private holdings, investment returns, compensation records, personal assets, and liabilities that are not fully available in the public information discussed in this article.
Read More: Isaac Avett: Fascinating Look Into Jennifer Carpenter’s Son’s Private Life
Matthew Schissler’s Investment and Advisory Career
After leaving CBAI, Matthew Schissler moved into a new phase focused on investments, advisory work, and board roles. Instead of leading one operating company, he began building influence through a broader portfolio of investment vehicles and business relationships.
His post-CBAI career included work with small-cap and mid-cap companies, where he used his experience in company building, strategy, and management. This shift toward portfolio management, private investment, and advisory roles shows how Schissler continued growing his business profile while creating a more diversified wealth strategy.
Matthew Schissler’s Role in Pyrenees Investments
Matthew Schissler serves as Managing Member of Pyrenees Investments LLC, a private consulting firm that supports small-cap and public company clients. Through the Pyrenees, he helps companies set up operations, build sales and marketing functions, manage compliance, and keep proper books and records. He also connects clients with legal, accounting, and finance professionals through his business network.
The firm works with more than a dozen small-cap clients at the same time, which gives Schissler a diversified consulting model instead of depending on one company’s performance. This makes Pyrenees Investments an important part of his post-CBAI career and net worth story because it creates advisory income, business relationships, and long-term service-based revenue.
Matthew Schissler’s Work Your Core Investment Strategy
Matthew Schissler’s Work Your Core Investment Strategy is centered on Work Your Core Investments LLC, a private investment vehicle he founded to support companies with strong growth potential. Instead of focusing on short-term trading, the firm appears to follow a long-term value creation approach built around private company investment, capital deployment, and business growth opportunities. Schissler’s role is also strengthened by his securities licenses, including Series 63 and Series 79, which qualify him as a registered securities professional and investment banking professional.
These credentials are important because the Series 79 license allows work in areas such as mergers and acquisitions advisory, private placements, capital markets activity, and other investment banking transactions. This makes Work Your Core Investments part of his wider net worth story because it shows a more structured investment strategy based on professional licensing, private capital, and long-term business value.
Matthew Schissler’s GHS Ownership Stake
Matthew Schissler reportedly holds about a 33 percent ownership stake in GHS Investments, which makes the firm an important part of his wider investment and net worth profile. GHS focuses on small-cap convertible note investments, a type of financing where loans made to smaller companies can later convert into equity under agreed conditions. This kind of structure is common in early-stage and small-cap financing because it gives companies access to capital while giving investors possible equity upside.
Schissler’s stake matters because it connects him to a specialized investment model built around small-cap funding, convertible debt, and long-term financial exposure. In simple terms, GHS Investments adds another layer to his wealth story by showing his involvement in equity-linked private investment beyond traditional company ownership.
Board Role at Aztec Airways
Matthew Schissler’s board role at Aztec Airways Inc. shows that his business influence reaches beyond healthcare and biotech. As a member of the Board of Directors at this regional private aviation company, he brings strategic value, executive experience, and advisory insight to another industry. This position also strengthens his professional reputation because it reflects cross-industry trust, not just a title. His connection with Aztec Airways highlights his wider business diversification and shows how his leadership role extends into the aviation sector.
Big League Wiffle Ball Explained
Big League Wiffle Ball stands out in Matthew Schissler’s board portfolio because it is different from his usual business roles. Instead of healthcare, biotech, or traditional investment sectors, this role connects him with an organized Wiffle ball league built around adult recreational sports.
Schissler serves as a Board Member, giving him a private company role in a sports venture with early-stage growth potential. This makes Big League Wiffle Ball more than just a recreational league; it shows how his investment philosophy can also target unique, growth-oriented companies with public interest and business appeal.
Frozen Food Gift Group Overview
Frozen Food Gift Group was one of Matthew Schissler’s more unusual business moves because it took him outside healthcare and into the specialty food market. In 2009, he co-founded the company with a partner, and it later traded publicly on the OTCBB under the ticker FROZ. The business focused on shipping specialty ice cream gifts across the United States, making it part of the consumer gifting and direct-to-consumer food market.
Schissler held about 36 percent ownership and also served on the Board of Directors, showing both financial involvement and operational interest. This venture highlighted his willingness to invest capital and business experience in completely different product categories.
Inside China Stem Cells Inc
Matthew Schissler’s role at China Stem Cells Inc. shows how his biotech experience moved beyond the U.S. market. He served as President of the company while also holding a minority shareholder position and working as an advisor. This role connected him directly with the stem cell industry in China and reflected his leadership in healthcare biotechnology.
It also showed how his technical and regulatory knowledge from CBAI could be applied in a different geographic market. By applying that background at China Stem Cells Inc., Schissler moved his biotech experience into international advisory work and the Chinese stem cell market.
IIOT-OXYS Inc. and Schissler’s Tech Role
Matthew Schissler’s role as Director of IIOT-OXYS Inc. shows his move into the technology sector beyond biotech. The company works in the industrial Internet of Things, industrial sensors, and health monitoring technology, which connects industrial systems with healthcare monitoring needs.
This board role gives Schissler a clear place in a growth-oriented tech company and reflects his interest in businesses where technology, healthcare, and data-driven monitoring overlap. It also shows a practical biotech-to-tech crossover in his wider business profile.
Matthew Schissler Net Worth 2026 and Business Wealth
The available information does not provide a verified calculation of Matthew Schissler’s total assets and liabilities. The $5 million to $10 million figure used in this article is therefore an estimate based on the business interests, reported ownership positions, investment activity, executive career, and other public information discussed on the page. Private assets and investment valuations can change, so the estimate should not be treated as an audited or officially reported net worth.
Potential Factors Behind Matthew Schissler’s Wealth Estimate
Several parts of Schissler’s public business history may be relevant when assessing his wealth, including private investment interests, reported ownership positions, consulting and advisory activities, executive experience, and corporate board roles. However, the available information does not establish the current value of each asset or provide complete figures for income, compensation, liabilities, investment returns, or private-company holdings.
For that reason, these activities should be viewed as potential contributors to his financial position, not as a verified earnings breakdown.
What Is Known and Unknown About His Wealth
Public information can establish parts of Matthew Schissler’s professional history, including his leadership at Cord Blood America, reported business ownership interests, investment-related activities, and board positions. These details help explain why he is associated with a multimillion-dollar wealth estimate.
What remains unclear is the current value of his private investments, personal assets, liabilities, compensation from individual roles, and investment returns. Without those figures, an exact net worth cannot be independently calculated from the information available on this page.
Matthew Schissler’s Business Journey
Matthew Schissler’s business journey stands out because he built his career around opportunities that many people noticed only later. He was not chasing fame, Forbes lists, or glamorous industries; he focused on smaller markets where timing, execution, and access mattered more. His biotech phase showed how he could raise capital, consolidate a niche healthcare market, and build investor confidence around an emerging medical service.
Over time, he moved into frozen food gifting, South American biotech, Chinese stem cells, regional aviation, and adult recreational sports leagues, showing a pattern of practical business diversification. His CBAI years became the clearest example of how he entered niche markets before wider investor attention arrived. Taken together, his career shows a small-cap investor and operator who builds real businesses before the broader market fully pays attention.
Matthew Schissler Career Timeline
| Year | Career Milestone |
|---|---|
| 1971 | Born June 9 |
| 1989–1993 | Studied Biology and Public Policy at St. Mary’s College of Maryland |
| 1993–1994 | Began career in sales at Delmarva Broadcasting |
| 1994–2001 | Worked at TMP Worldwide and progressed to Senior Regional Director |
| 2001 | Founded RainMakers International |
| 2003 | Co-founded Cord Blood America |
| 2005–2006 | CBAI pursued major acquisitions |
| 2008 | Named a Los Angeles regional semi-finalist for Entrepreneur of the Year |
| 2009 | Co-founded Frozen Food Gift Group |
| 2012 | Left Chairman and CEO roles at CBAI |
| 2012 onward | Expanded into investment, consulting, advisory, and board activities |
| 2026 | Net worth remains an estimated $5 million–$10 million |
Frequantely Asked Questions(FAQ;s)
What is Matthew Schissler’s net worth in 2026?
Matthew Schissler’s estimated net worth in 2026 is $5 million to $10 million. However, the amount remains an approximation because Schissler has not publicly disclosed a full record of his assets, investments, and liabilities.
Who is Matthew L. Schissler?
Matthew L. Schissler is an American entrepreneur and investor whose career has included advertising, biotechnology, private investments, consulting, and corporate business roles. He is particularly known for his leadership at Cord Blood America.
How did Matthew Schissler make his money?
Schissler’s professional history includes executive leadership, business ownership interests, investments, consulting, and advisory activities. These areas may have contributed to his financial position, but detailed income and investment-return figures are not publicly available.
What is Matthew Schissler known for?
He is best known for his involvement with Cord Blood America, where he served as Chairman and CEO. His later career included investment and advisory activities across several businesses and industries.
Did Matthew Schissler own Cord Blood America?
Matthew Schissler was a co-founder and executive leader of Cord Blood America. He served as Chairman and CEO during the company’s development and remained associated with the company until 2012.
Is Matthew Schissler’s net worth officially confirmed?
No. The $5 million to $10 million figure should be treated as an estimate rather than an officially reported net worth. Publicly accessible records do not reveal the full value of his personal holdings, private investments, or outstanding obligations.
What businesses has Matthew Schissler been involved with?
His reported business history includes Cord Blood America and later investment, consulting, and corporate activities involving companies such as Pyrenees Investments, Work Your Core Investments, GHS Investments, and other business interests discussed in this article.
Why is Matthew Schissler’s exact net worth difficult to determine?
An exact figure is difficult to establish because private investments, personal assets, liabilities, compensation, and investment returns are not fully disclosed in the available public information. The value assigned to privately held companies may fluctuate as market conditions and business performance change.
Read More: Charles Quincy Ascher Einstein: A Remarkable Family Legacy and Innovation
SEO specialist with 5+ years of experience in On-Page, Technical, and Off-Page SEO. I help websites and e-commerce stores rank higher on Google and drive consistent organic traffic through strategic SEO and keyword optimization.